18 Results for "

DAPK1

" in MedChemExpress (MCE) Product Catalog:
Products (18)

18 Results for "DAPK1" in MCE Product Catalog:

15
15 Publications Verification
Cat. No.: HY-15513
CAS No.: 315694-89-4
Purity:  96.87%
Target:  

DAPK

Research Areas:  

Cancer

TC-DAPK 6 is a potent, ATP-competitive, and highly selective DAPK inhibitor (IC50=69 and 225 nM against DAPK1 and DAPK3, respectively, with 10 μM ATP).
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-15847
CAS No.: 1030203-81-6
Purity:  99.91%
Target:  

DAPK

Research Areas:  

Cardiovascular Disease

HS38 is a potent, selective, and ATP-competitive inhibitor of death-associated protein kinase 1 (DAPK1) and zipper-interacting protein kinase (ZIPK, also called DAPK3), with Kds of 300 nM and 280 nM, respectively. HS38 is also a PIM3 inhibitor with an IC50 of 200 nM. HS38 can be used for the research of smooth muscle related disorders [1].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-123581
CAS No.: 81810-66-4
Purity:  98.00%
Quinocetone is an orally active animal feed additive used to increase the meat production of livestock and poultry. Quinocetone exhibits antibacterial activity against a variety of pathogenic microorganisms. Quinocetone exhibits tissue-specific (liver, lymphocyte) toxicity. Quinocetone induces autophagy in cells through the ATF6/DAPK1 pathway. Quinocetone activates the NF-κB and iNOS pathways, leading to cell apoptosis, hepatocyte vacuolar degeneration and fibrosis. Quinocetone can inhibit Nrf2/HO-1 and induce the generation of reactive oxygen species (ROS), leading to oxidative stress and DNA damage [1] .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-112056
CAS No.: 151358-48-4
Purity:  99.47%
DIM-C-pPhCO2Me is a nuclear receptor 4A1 (NR4A1) antagonist. DIM-C-pPhCO2Me induces Apoptosis. DIM-C-pPhCO2Me decreases PAX3-FOXO1A, N-Myc, Rassf4, MyoD1, Grem1, and DAPK1 proteins. DIM-C-pPhCO2Me decreases expression of TXNDC5 and IDH1, induces markers of ER stress (CHOP, ATF4 and p-PERK). DIM-C-pPhCO2Me inhibits renal cell carcinoma, breast cancer. DIM-C-pPhCO2Me can also be used in rhabdomyosarcoma research [1] .
loading...
    loading...
Cat. No.: HY-179055
CAS No.: 3063030-38-3
Target:  

PROTACs DAPK

Research Areas:  

Neurological Disease

PROTAC DAPK1 Degrader-1 (Compound CP1) is a DAPK1 PROTAC degrader with a DC50 of 119.6 nM. PROTAC DAPK1 Degrader-1 significantly increased the MDM2 protein level. PROTAC DAPK1 Degrader-1 significantly reduced the levels of cleaved caspase-3 and cleaved PARP in a cell apoptosis model induced by the neurotoxin ceramide, indicating that it effectively inhibits neuronal apoptosis by degrading DAPK1. PROTAC DAPK1 Degrader-1 can be used to study neurological diseases such as cerebral ischemia and traumatic brain injury (pink: DAPK1 ligand (HY-179071); blue: CRBN ligand (HY-10984); black: linker (HY-40171)) [1].
loading...
    loading...
Cat. No.: HY-169109
CAS No.: 1429522-04-2
Target:  

DAPK

Research Areas:  

Neurological Disease

DAPK1-IN-1 (compound 10) is a death-associated protein kinase 1 (DAPK1) inhibitor with a Kd value of 0.63 μM. DAPK1-IN-1 can be used in Alzheimer’s disease research [1].
loading...
    loading...
Cat. No.: HY-179071
CAS No.: 3057532-78-9
DAPK1 ligand-1 is a PROTAC target protein ligand that can be used for synthesis of PROTACs, such as PROTAC DAPK1 Degrader-1 (HY-179055). PROTAC DAPK1 Degrader-1 is a potent LAG-3 PROTAC degrader with neuroprotective activity [1].
loading...
    loading...
Cat. No.: HY-RS03527
Research Areas:  

Others

DAPK1 Human Pre-designed siRNA Set A contains three designed siRNAs for DAPK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS16812
Research Areas:  

Others

Dapk1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Dapk1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS23252
Research Areas:  

Others

Dapk1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Dapk1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-P5277
CAS No.: 1587742-50-4
Target:  

DAPK

Research Areas:  

Neurological Disease

TAT-GluN2BCTM is a membrane-permeable DAPK1-targeting peptide. TAT-GluN2BCTM targets active DAPK1 to lysosomes for degradation. TAT-GluN2BCTM protects neurons from oxidative stress and NMDAR-mediated excitotoxicity by knocking down DAPK1. TAT-GluN2BCTM can be used in the study of neuroprotection [1].
loading...
    loading...
Cat. No.: HY-175477
CAS No.: 2967648-29-7
Research Areas:  

Cancer

UNC9750 is an inositol phosphate multikinase (IPMK) inhibitor with IC50 values ​​of 31.6 and 374 nM for IPMK and IP6K2, respectively.. UNC9750 inhibits cellular accumulation of InsP5, the direct product of IPMK kinase activity, while having no effect on either InsP6 or InsP7 levels. UNC9750 has ≥ 75% inhibition of four kinases (DAPK1, DYRK1B, PDGFR, and KDR). UNC9750 can be used for the study of glioblastoma [1].
loading...
    loading...
Cat. No.: HY-123581R
CAS No.: 81810-66-4
Quinocetone (Standard) is the analytical standard of Quinocetone (HY-123581). This product is used for research and analytical purposes. Quinocetone is an orally active animal feed additive used to increase the meat production of livestock and poultry. Quinocetone exhibits antibacterial activity against a variety of pathogenic microorganisms. Quinocetone exhibits tissue-specific (liver, lymphocyte) toxicity. Quinocetone induces autophagy in cells through the ATF6/DAPK1 pathway. Quinocetone activates the NF-κB and iNOS pathways, leading to cell apoptosis, hepatocyte vacuolar degeneration and fibrosis. Quinocetone can inhibit Nrf2/HO-1 and induce the generation of reactive oxygen species (ROS), leading to oxidative stress and DNA damage.
loading...
    loading...
Cat. No.: HY-131909
CAS No.: 2226742-61-4
Research Areas:  

Cancer

CJ-2360 is a potent and orally active ALK inhibitor with IC50s of 2.2, 4.0, 8.8, 6.3, and 8.9 nM against wild-type ALK and F1197M, G1269A, L1196M, and S1206Y ALK mutants, respectively. CJ-2360 displays potent inhibitory activity against two clinically reported ALK mutants (C1156Y and L1196M) and a few other kinases (LTK, MERTK, CLK1, DAPK1, and DAPK2) among the 468 kinases evaluated [1].
loading...
    loading...
Cat. No.: HY-P83053
Synonyms: DAK1; DAP K1; DAP kinase 1; DAPK 1; DAPK; DAPK1; DAPK1_HUMAN; Death Associated Protein Kinase 1; Death-associated protein kinase 1

Host:  

Rabbit

Application:  

WB, IHC-P, ICC/IF

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
Cat. No.: HY-125404
CAS No.: 313971-05-0
DAPK-IN-1 is a DAPK1 and DAPK3 inhibitor. DAPK-IN-1 is applicable to research related to cerebral infarction, myocardial infarction and renal failure [1].
loading...
    loading...
Cat. No.: HY-P76858
Purity:  ≥ 80%, as determined by reducing SDS-PAGE.
Synonyms: Death-associated protein kinase 1; DAP kinase 1; DAPK
Species:  
Source:  
loading...
    loading...
Cat. No.: HY-P702657
Purity:  ≥ 88%, as determined by reducing SDS-PAGE.
Synonyms: Death-associated protein kinase 1; DAP kinase 1; DAPK
Species:  
Source:  
loading...
    loading...
  • 1